Abstract
Background
Nodal metastasis is an important clinical issue in gastric cancer patients. This study was designed to investigate the clinical usefulness of the positive lymph node ratio (PLNR), which reflects both metastatic and retrieved lymph node numbers, in patients with pN3 gastric cancer.
Methods
We retrospectively analyzed the records of 138 consecutive pN3 patients who underwent curative gastrectomy with lymphadenectomy from 2000 to 2012.
Results
A PLNR of 0.4 was proved to be the best cutoff value to stratify the prognosis of patients with pN3 gastric cancer (P < 0.001). Univariate and multivariate analyses revealed that older age, larger tumor size (≥10 cm), and PLNR ≥ 0.4 [P < 0.001, HR 3.1 (95 % CI 1.7–5.4)] were independent prognostic factors in pN3 gastric cancer. Regarding the recurrence, patients with PLNR <0.4 had a significantly lower rate of lymph node recurrence than those with PLNR ≥0.4 (P = 0.020). There was no significant difference in the lymph node recurrence rate between N3a and N3b patients in the PLNR <0.4 group [P = 0.546, 11.6 % (7/60) vs. 12.5 (1/8)], indicating a better local control regardless of pN3 subgroups.
Conclusions
PLNR is useful to stratify the prognosis and evaluate the extent of local tumor clearance in pN3 gastric cancer.
Similar content being viewed by others
References
Ferlay J, Soerjomataram I, Dikshit R, et al.: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-E386.
Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. : Gastric cancer. The Lancet 2009; 374: 477-490.
Kawaguchi T, Komatsu S, Ichikawa D, et al.: Clinical significance and prognostic impact of the total diameter of enlarged lymph nodes on preoperative multidetector computed tomography in patients with gastric cancer. J Gastroenterol Hepatol 2015;30(11):1603-1609.
Bonenkamp JJ, Hermans J, Sasako M, et al.: Extended lymph-node dissection for gastric cancer. New England Journal of Medicine 1999; 340: 908-914.
Strong VE, Song KY, Park CH, et al.: Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg 2010;251:640-646.
Bickenbach K, Strong VE. Comparison of Gastric Cancer Treatments: East vs. West. J Gastric Cancer 2012;12: 55-62.
Strong VE, Yoon SS.: Extended Lymphadenectomy in Gastric Cancer Is Debatable. World journal of surgery 2013; 37: 1773-1777.
Degiuli M, Sasako M, Ponti A.: Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. British Journal of Surgery 2010; 97: 643-649.
Songun I, Putter H, Kranenbarg EMK, et al.: Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. The lancet oncology 2010; 11: 439-449.
Komatsu S, Ichikawa D, Okamoto K, et al.: Differences of the lymphatic distribution and surgical outcomes between remnant gastric cancers and primary proximal gastric cancers. J Gastrointest Surg 2012 ;16(3):503-508.
Pawlik TM, Gleisner AL, Cameron JL, et al.: Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 2007 ;141:610-618.
Herr HW.: Superiority of ratio based lymph node staging for bladder cancer. J Urol 2003;169:943-945.
Rosenberg R, Friederichs J, Schuster T, et al.: Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period. Ann Surg 2008;248:968-978.
Kulig J, Sierzega M, Kolodziejczyk P, et al.; Polish Gastric Cancer Study Group: Ratio of metastatic to resected lymph nodes for prediction of survival in patients with inadequately staged gastric cancer. Br J Surg 2009;96:910-918.
Marchet A, Mocellin S, Ambrosi A, et al.; Italian Research Group for Gastric Cancer (IRGGC): The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 2007;245:543-552.
Nakajima T.: Gastric cancer treatment guidelines in Japan. Gastric Cancer 2002;5:1-5.
Japanese Gastric Cancer Association: Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011; 14:113–123.
Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011; 14:101–112.
Sobin L, Gospodarowicz M, Wittekind C, et al.: International union against cancer. TNM classification of malignant tumours, 7th edition. New York: Wiley-Blackwell; 2010.
Okajima W, Komatsu S, Ichikawa D, et al.: Prognostic impact of the number of retrieved lymph nodes in patients with gastric cancer. J Gastroenterol Hepatol. 2016 Feb 3. doi: 10.1111/jgh.13306. Epub ahead of print,
Rodríguez Santiago JM, Muñoz E, Martí M, et al.; Metastatic lymph node ratio as a prognostic factor in gastric cancer. Eur J Surg Oncol 2005;31:59–66.
Kunisaki C, Shimada H, Nomura M, et al.; Clinical impact of metastatic lymph node ratio in advanced gastric cancer. Anticancer Res 2005;25:1369–1375.
Bando E, Yonemura Y, Taniguchi K, et al.; Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 2002;9:775–784.
Sun Z, Zhu GL, Lu C, et al.; The impact of N-ratio in minimizing stage migration phenomenon in gastric cancer patients with insufficient number or level of lymph node retrieved: results from a Chinese mono-institutional study in 2159 patients. Ann Oncol 2009;20:897-905.
Wong J, Rahman S, Saeed N, et al.; Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience. J Gastrointest Surg 2013;17:2059-2066.
Wu XJ, Miao RL, Li ZY, et al.; Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer. Eur J Surg Oncol 2015;41:927-933.
Kutlu OC, Watchell M, Dissanaike S. Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients. Surg Oncol 2015;24:84-88
Kodera Y, Yamamura Y, Shimizu Y, et al.; Lymph node status assessment for gastric carcinoma: is the number of metastatic lymph nodes really practical as a parameter for N categories in the TNM Classification? Tumor Node Metastasis. J Surg Oncol 1998;69:15–20.
Kim C, Yang D. Adjustment of N stages of gastric cancer by the ratio between the metastatic and examined lymph nodes. Ann Surg Oncol 2009;16:1868–1874.
Kong SH, Lee HJ, Ahn HS, et al.: Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: the reappraisal of positive lymph node ratio as a proper N-staging. Ann Surg 2012;255:50-58.
Authors’ contributions
Shuhei Komatsu, Daisuke Ichikawa, Mahito Miyamae, Toshiyuki Kosuga, Kazuma Okamoto, Tomohiro Arita, Hirotaka Konishi, Ryo Morimura, Yasutoshi Murayama, Atsushi Shiozaki, Yoshiaki Kuriu, Hisashi Ikoma, Masayoshi Nakanishi, Hitoshi Fujiwara, and Eigo Otsuji performed the research and analyzed data, and Shuhei Komatsu wrote the paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Komatsu, S., Ichikawa, D., Miyamae, M. et al. Positive Lymph Node Ratio as an Indicator of Prognosis and Local Tumor Clearance in N3 Gastric Cancer. J Gastrointest Surg 20, 1565–1571 (2016). https://doi.org/10.1007/s11605-016-3197-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-016-3197-9